BioSpace News Archive

-- GAVRETO, the only once-daily RET-targeted therapy, demonstrated durable efficacy, with complete responses in a subset of patients -- -- Blueprint Medicines and Genentech will co-commercialize GAVRETO in the U.S. -- -- FDA approval underscores Blueprint Medicines’ commitment to deliver a portfolio of transformative precision therapies to patients with NSCLC -- -- NDA accepted by FDA for pralsetinib for RET-mutant medullary thyroid cancer and RET fusion-positive th

Freezing is recommended for preservation during COVID-19 but may cause stem cell products to become less viable

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, today announced that Vu Truong , Ph.D., Chief Executive Officer, will present at the following investor conferences in September:

Invacare Corporation (“Invacare”)(NYSE:IVC), a leading manufacturer and distributor of medical equipment used in non-acute care settings, has been recognized by Mobility Management magazine in multiple product categories for outstanding product and technology development in complex rehab. “Invacare is honored that

Each year, New Jersey’s 49 birthing hospitals welcome more than 100,000 babies into the world, and they have committed themselves to ensuring the safety and well-being of the mothers and babies in their care.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company approved the grant of equity awards to four new employees with grant date of September 1, 2020, as equity inducement awards outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

Amgen (NASDAQ:AMGN) will present at Citi’s 15th Annual Virtual BioPharma Conference at 2:25 p.m. ET on Thursday, Sept. 10, 2020 . Murdo Gordon , executive vice president of Global Commercial Operations at Amgen and Peter H. Griffith , executive vice president and chief financial officer, will present at the conference. Li

Hologic, Inc. announced that the Company will present at these upcoming virtual investor conferences

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions announces the following:

Quanta, Inc. today announced another virtual “Town Hall” style investor event, which will be broadcast live over the internet on September 10, 2020 at 1:30 PM ET / 10:30 AM PT.